Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Castillo

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|November 29, 2023
Corrigendum: Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicityYiwei Shen, Kamala Vanarsa, Zhihua Yin, et al.
Frontiers in Immunology|September 18, 2023
Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicityYiwei Shen, Kamala Vanarsa, Zhihua Yin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 3, 2020
CSF chitinase 3-like-1 association with disability of primary progressive MSFrancisco Pérez-Miralles, Daniel Prefasi, Antonio García-Merino, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 22, 2024
Renal function's impact on serum neurofilament levels in patients with multiple sclerosis: an exploratory analysisJordi Tortosa-Carreres, Laura Cubas-Núñez, Maria Teresa Sanz, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 13, 2026
miRNA Signature in CSF From Patients With Primary Progressive Multiple SclerosisMaría Muñoz-San Martín, Imma Gómez, Ana Quiroga-Varela, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 1, 2023
miRNA Signature in CSF From Patients With Primary Progressive Multiple SclerosisMaría Muñoz-San Martín, Imma Gómez, Ana Quiroga-Varela, et al.
Microorganisms|May 27, 2026
Inhibitors of the FASII Metabolic Pathway in <i>Toxoplasma gondii</i>: Advances and Therapeutic PerspectivesClaudia Jessica Castillo-Villanueva, Jhony Anacleto-Santos, Teresa de Jesús López-Pérez, et al.
Multiple Sclerosis and Related Disorders|June 4, 2026
Relapse-associated versus relapse-independent progression determines disability trajectories in multiple sclerosis beyond EDSS 3.0Carmen Alcalá-Vicente, Jordi Tortosa-Carreres, Laura Cubas-Núñez, et al.
Multiple Sclerosis and Related Disorders|September 15, 2023
Improving the efficiency of free kappa light chains as diagnostic biomarker of Multiple Sclerosis by using a novel algorithmJordi Tortosa-Carreres, Anna Quiroga-Varela, Jessica Castillo-Villalba, et al.
Heliyon|June 19, 2025
Corrigendum to "Integrated genomic, proteomic and cognitive assessment in Duchenne Muscular Dystrophy suggest astrocyte centric pathology" [Heliyon Volume 9, Issue 8, August 2023, Article e18530]Nalaka Wijekoon, Lakmal Gonawala, Pyara Ratnayake, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|November 29, 2023
Corrigendum: Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicityYiwei Shen, Kamala Vanarsa, Zhihua Yin, et al.
Frontiers in Immunology|September 18, 2023
Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicityYiwei Shen, Kamala Vanarsa, Zhihua Yin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 3, 2020
CSF chitinase 3-like-1 association with disability of primary progressive MSFrancisco Pérez-Miralles, Daniel Prefasi, Antonio García-Merino, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 22, 2024
Renal function's impact on serum neurofilament levels in patients with multiple sclerosis: an exploratory analysisJordi Tortosa-Carreres, Laura Cubas-Núñez, Maria Teresa Sanz, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 13, 2026
miRNA Signature in CSF From Patients With Primary Progressive Multiple SclerosisMaría Muñoz-San Martín, Imma Gómez, Ana Quiroga-Varela, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 1, 2023
miRNA Signature in CSF From Patients With Primary Progressive Multiple SclerosisMaría Muñoz-San Martín, Imma Gómez, Ana Quiroga-Varela, et al.
Microorganisms|May 27, 2026
Inhibitors of the FASII Metabolic Pathway in <i>Toxoplasma gondii</i>: Advances and Therapeutic PerspectivesClaudia Jessica Castillo-Villanueva, Jhony Anacleto-Santos, Teresa de Jesús López-Pérez, et al.
Multiple Sclerosis and Related Disorders|June 4, 2026
Relapse-associated versus relapse-independent progression determines disability trajectories in multiple sclerosis beyond EDSS 3.0Carmen Alcalá-Vicente, Jordi Tortosa-Carreres, Laura Cubas-Núñez, et al.
Multiple Sclerosis and Related Disorders|September 15, 2023
Improving the efficiency of free kappa light chains as diagnostic biomarker of Multiple Sclerosis by using a novel algorithmJordi Tortosa-Carreres, Anna Quiroga-Varela, Jessica Castillo-Villalba, et al.
Heliyon|June 19, 2025
Corrigendum to "Integrated genomic, proteomic and cognitive assessment in Duchenne Muscular Dystrophy suggest astrocyte centric pathology" [Heliyon Volume 9, Issue 8, August 2023, Article e18530]Nalaka Wijekoon, Lakmal Gonawala, Pyara Ratnayake, et al.
Pageof 5